» Articles » PMID: 31783130

CNS Organoids: an Innovative Tool for Neurological Disease Modeling and Drug Neurotoxicity Screening

Overview
Specialty Pharmacology
Date 2019 Nov 30
PMID 31783130
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The paradigm of central nervous system (CNS) drug discovery has mostly relied on traditional approaches of rodent models or cell-based in vitro models. Owing to the issues of species differences between humans and rodents, it is difficult to correlate the robustness of data for neurodevelopmental studies. With advances in the stem-cell field, 3D CNS organoids have been developed and explored owing to their resemblance to the human brain architecture and functions. Further, CNS organoids provide a unique opportunity to mimic the human brain physiology and serve as a modeling tool to study the normal versus pathological brain or the elucidation of mechanisms of neurological disorders. Here, we discuss the recent application of a CNS organoid explored for neurodevelopment disease or a screening tool for CNS drug development.

Citing Articles

A Comprehensive Review on Utilizing Human Brain Organoids to Study Neuroinflammation in Neurological Disorders.

Rubio A, Hamilton L, Bausch M, Jin M, Papetti A, Jiang P J Neuroimmune Pharmacol. 2025; 20(1):23.

PMID: 39987404 PMC: 11846768. DOI: 10.1007/s11481-025-10181-x.


Electrode- and Label-Free Assessment of Electrophysiological Firing Rates through Cytochrome C Monitoring via Raman Spectroscopy.

Tentellino C, dAmora M, Melikov R, Iachetta G, Bruno G, Tantussi F ACS Sens. 2025; 10(2):1228-1236.

PMID: 39907650 PMC: 11877498. DOI: 10.1021/acssensors.4c03133.


Brain organoids: A new tool for modelling of neurodevelopmental disorders.

Aili Y, Maimaitiming N, Wang Z, Wang Y J Cell Mol Med. 2024; 28(17):e18560.

PMID: 39258535 PMC: 11388061. DOI: 10.1111/jcmm.18560.


Organoids Modeling Stroke in a Petri Dish.

Giorgi C, Castelli V, dAngelo M, Cimini A Biomedicines. 2024; 12(4).

PMID: 38672231 PMC: 11048104. DOI: 10.3390/biomedicines12040877.


Pluripotent stem cells for target organ developmental toxicity testing.

Wu X, Chen Y, Kreutz A, Silver B, Tokar E Toxicol Sci. 2024; 199(2):163-171.

PMID: 38547390 PMC: 11131012. DOI: 10.1093/toxsci/kfae037.


References
1.
Keller Jr R, Snyder-Keller A . Prenatal cocaine exposure. Ann N Y Acad Sci. 2000; 909:217-32. DOI: 10.1111/j.1749-6632.2000.tb06684.x. View

2.
Seo J, Kritskiy O, Watson L, Barker S, Dey D, Raja W . Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia. J Neurosci. 2017; 37(41):9917-9924. PMC: 5637118. DOI: 10.1523/JNEUROSCI.0621-17.2017. View

3.
Broutier L, Andersson-Rolf A, Hindley C, Boj S, Clevers H, Koo B . Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation. Nat Protoc. 2016; 11(9):1724-43. DOI: 10.1038/nprot.2016.097. View

4.
Quadrato G, Brown J, Arlotta P . The promises and challenges of human brain organoids as models of neuropsychiatric disease. Nat Med. 2016; 22(11):1220-1228. DOI: 10.1038/nm.4214. View

5.
Sloan S, Darmanis S, Huber N, Khan T, Birey F, Caneda C . Human Astrocyte Maturation Captured in 3D Cerebral Cortical Spheroids Derived from Pluripotent Stem Cells. Neuron. 2017; 95(4):779-790.e6. PMC: 5890820. DOI: 10.1016/j.neuron.2017.07.035. View